Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Flowserve
FLS
$10.3B
| $1.11M | 0.02% |
22,296
-43,061
| -66% | -$2.06M |
|
602
Repligen
RGEN
$10.3B
| $1.11M | 0.02% |
11,995
-27,703
| -70% | -$2.33M |
|
603
Oceaneering
OII
$5.02B
| $1.1M | 0.02% |
+73,691
| New | +$1.03M |
|
|
KAMN
604
DELISTED
Kaman Corp
KAMN
| $1.1M | 0.02% |
+16,621
| New | +$1.04M |
|
|
FBM
605
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $1.09M | 0.02% |
56,352
+21,072
| +60% | +$404K |
|
606
Sanmina
SANM
$10B
| $1.08M | 0.02% |
31,444
+10,269
| +48% | +$329K |
|
607
Trade Desk
TTD
$6.21B
| $1.08M | 0.02% |
41,460
-24,300
| -37% | -$547K |
|
608
Alexandria Real Estate Equities
ARE
$9.32B
| $1.07M | 0.02% |
6,635
-635
| -9% | -$100K |
|
609
Boston Properties
BXP
$11.2B
| $1.06M | 0.02% |
7,728
+1,315
| +21% | +$177K |
|
610
Core Laboratories
CLB
$556M
| $1.05M | 0.02% |
27,938
-29,555
| -51% | -$1.33M |
|
611
Cognizant
CTSH
$28B
| $1.05M | 0.02% |
16,901
-1,322
| -7% | -$81.7K |
|
612
Essex Property Trust
ESS
$18.8B
| $1.04M | 0.02% |
3,473
+30
| +0.9% | +$9.48K |
|
613
Antero Midstream
AM
$10.5B
| $1.04M | 0.02% |
+136,802
| New | +$865K |
|
|
TGNA
614
DELISTED
TEGNA Inc
TGNA
| $1.03M | 0.02% |
61,924
-57,187
| -48% | -$890K |
|
615
Public Service Enterprise Group
PEG
$36.6B
| $1.03M | 0.02% |
17,478
-34,413
| -66% | -$2.09M |
|
616
Boise Cascade
BCC
$2.86B
| $1.02M | 0.02% |
+27,873
| New | +$1.01M |
|
617
Asbury Automotive
ABG
$3.82B
| $1.01M | 0.02% |
9,023
-433
| -5% | -$46.6K |
|
618
JELD-WEN Holding
JELD
$212M
| $1.01M | 0.02% |
43,022
-27,460
| -39% | -$565K |
|
619
Anika Therapeutics
ANIK
$286M
| $1M | 0.02% |
19,378
+9,356
| +93% | +$543K |
|
620
Akamai
AKAM
$15.3B
| $998K | 0.02% |
11,549
+7,805
| +208% | +$682K |
|
621
EverQuote
EVER
$944M
| $991K | 0.02% |
+28,853
| New | +$804K |
|
|
ANSS
622
DELISTED
Ansys
ANSS
| $985K | 0.02% |
3,827
-8,176
| -68% | -$1.93M |
|
623
e.l.f. Beauty
ELF
$6.21B
| $984K | 0.02% |
60,990
-20,400
| -25% | -$339K |
|
624
Exelon
EXC
$45.7B
| $981K | 0.02% |
+30,168
| New | +$977K |
|
625
Koppers
KOP
$853M
| $977K | 0.02% |
25,557
+8,962
| +54% | +$315K |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.